Indicators of NK cell function such as high expression of NK cell-activating receptors and high cytotoxic or IFN-γ secreting properties have been linked to decreased metastatic load in multiple cohorts of cancer patients with risk of metastatic disease, suggesting their clinically relevant protective role [87]. The gene discussed is IFNG; the disease is cancer.